Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeuroEPO in Parkinson Disease
NCT04110678Phase 2Completed
- Sponsor
- International Center for Neurological Restoration
- Start
- Nov 2015
- Primary completion
- Feb 2016
- Modality
- Inhalation Devices, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of NeuroEPO in Parkinson's disease (PD), sponsored by International Center for Neurological Restoration. Started Nov 2015; status: completed.
02
Drugs
NeuroEPO
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04110678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04110678.